Loading clinical trials...
Loading clinical trials...
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel Study of Oral 6R-BH4 in Subjects With Isolated Systolic Hypertension and Endothelial Dysfunction
Conditions
Interventions
6R-BH4
Placebo
Locations
1
United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
December 1, 2008
Primary Completion Date
May 1, 2009
Completion Date
May 1, 2009
Last Updated
August 21, 2017
NCT07460960
NCT07324902
NCT05000515
NCT04087655
NCT05808686
NCT05812755
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions